Daniel C. Adelman

4.5k total citations · 1 hit paper
78 papers, 3.1k citations indexed

About

Daniel C. Adelman is a scholar working on Immunology and Allergy, Immunology and Surgery. According to data from OpenAlex, Daniel C. Adelman has authored 78 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology and Allergy, 18 papers in Immunology and 15 papers in Surgery. Recurrent topics in Daniel C. Adelman's work include Food Allergy and Anaphylaxis Research (21 papers), Allergic Rhinitis and Sensitization (12 papers) and Celiac Disease Research and Management (12 papers). Daniel C. Adelman is often cited by papers focused on Food Allergy and Anaphylaxis Research (21 papers), Allergic Rhinitis and Sensitization (12 papers) and Celiac Disease Research and Management (12 papers). Daniel C. Adelman collaborates with scholars based in United States, Germany and United Kingdom. Daniel C. Adelman's co-authors include Eric Holmgren, Kim Margolin, Michael S. Gordon, Robert S. Benjamin, George W. Sledge, Moshe Talpaz, S. Shak, Alkis Togias, Andrew Saxon and Emmanuel Saltiel and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Daniel C. Adelman

74 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

2001 744 citations Daniel C. Adelman et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel C. Adelman	803	756	714	569	493	78	3.1k
Lazaros I. Sakkas	716 0.9×	421 0.6×	549 0.8×	129 0.2×	266 0.5×	151	4.6k
Yun Jong Lee	771 1.0×	405 0.5×	467 0.7×	124 0.2×	371 0.8×	174	3.7k
L B van de Putte	694 0.9×	393 0.5×	237 0.3×	341 0.6×	232 0.5×	79	5.2k
Rajesh Malik	648 0.8×	629 0.8×	959 1.3×	299 0.5×	359 0.7×	88	2.3k
Diarmuid P. O’Donoghue	585 0.7×	1.7k 2.2×	648 0.9×	80 0.1×	155 0.3×	104	3.9k
Katashi Fukao	1.2k 1.5×	1.2k 1.6×	915 1.3×	108 0.2×	213 0.4×	175	4.7k
Federico Díaz‐González	867 1.1×	515 0.7×	378 0.5×	1.1k 1.9×	285 0.6×	163	4.3k
Kazunori Takeda	367 0.5×	1.5k 2.0×	628 0.9×	141 0.2×	403 0.8×	112	3.1k
S Thiru	1.2k 1.5×	470 0.6×	588 0.8×	202 0.4×	426 0.9×	112	5.4k
Amato de Paulis	1.3k 1.7×	704 0.9×	549 0.8×	916 1.6×	1.1k 2.3×	161	5.3k

Countries citing papers authored by Daniel C. Adelman

Since Specialization

Citations

This map shows the geographic impact of Daniel C. Adelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Adelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Adelman more than expected).

Fields of papers citing papers by Daniel C. Adelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Adelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Adelman. The network helps show where Daniel C. Adelman may publish in the future.

Co-authorship network of co-authors of Daniel C. Adelman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Adelman. A scholar is included among the top collaborators of Daniel C. Adelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Adelman. Daniel C. Adelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Casale, Thomas B., Edwin W. Tucker, Jinwei Yuan, et al.. (2025). Initial results from BEACON, a phase 1b/2a dose escalation study of the anti-c-Kit briquilimab antibody in adults with chronic spontaneous urticaria (CSU). Journal of Allergy and Clinical Immunology. 155(2). AB435–AB435. 1 indexed citations

Nilsson, Caroline, Andrea Vereda, Magnus P. Borres, et al.. (2024). Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial. Clinical and Translational Allergy. 14(1). e12326–e12326. 1 indexed citations

Chinthrajah, R. Sharon, Stacie M. Jones, Edwin Kim, et al.. (2022). Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy. Journal of Allergy and Clinical Immunology. 149(6). 2166–2170.e1. 45 indexed citations

Brown, Kari, James R. Baker, Andrea Vereda, et al.. (2021). Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials. Journal of Allergy and Clinical Immunology. 149(6). 2043–2052.e9. 15 indexed citations

Jones, Stacie M., Brian P. Vickery, J. Andrew Bird, et al.. (2017). At-home Dosing Adherence During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy. Journal of Allergy and Clinical Immunology. 139(2). AB256–AB256. 1 indexed citations

Leffler, Daniel A., Sarah Acaster, Katy Gallop, et al.. (2017). A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development. Value in Health. 20(4). 637–643. 29 indexed citations

Krug, Lee M., Jeffrey Crawford, David S. Ettinger, et al.. (2011). Phase II Multicenter Trial of Voreloxin as Second-Line Therapy in Chemotherapy-Sensitive or Refractory Small Cell Lung Cancer. Journal of Thoracic Oncology. 6(2). 384–386. 18 indexed citations

Siegel, Matthew, Mitchell Garber, Andrew Spencer, et al.. (2011). Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials. Digestive Diseases and Sciences. 57(2). 440–450. 78 indexed citations

Corren, Jonathan, Gail Shapiro, James D. Reimann, et al.. (2008). Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy. Journal of Allergy and Clinical Immunology. 121(2). 506–511. 50 indexed citations

10.

Heath, Elisabeth I., Keith C. Bible, Robert E. Martell, Daniel C. Adelman, & Patricia LoRusso. (2007). A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors. Investigational New Drugs. 26(1). 59–65. 89 indexed citations

11.

Corren, Jonathan, David Díaz-Sánchez, Andrew Saxon, et al.. (2004). Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis. Annals of Allergy Asthma & Immunology. 93(3). 243–248. 24 indexed citations

12.

Hongo, Yoichiro, Krishnankutty Sudhir, Daniel C. Adelman, et al.. (2003). Incidence and characteristics of ruptured plaque in Femoro-Popliteal arteries. Journal of the American College of Cardiology. 41(6). 303–304. 1 indexed citations

13.

Chou, Tony M., Kathryn W. Woodburn, Wai‐Fung Cheong, et al.. (2002). Photodynamic therapy: Applications in atherosclerotic vascular disease with motexafin lutetium. Catheterization and Cardiovascular Interventions. 57(3). 387–394. 32 indexed citations

14.

FAHY, JOHN V., Donald W. Cockcroft, Louis‐Philippe Boulet, et al.. (1999). Effect of Aerosolized Anti-IgE (E25) on Airway Responses to Inhaled Allergen in Asthmatic Subjects. American Journal of Respiratory and Critical Care Medicine. 160(3). 1023–1027. 121 indexed citations

15.

Shearer, William T., et al.. (1994). Core content outline for clinical and laboratory immunology. Journal of Allergy and Clinical Immunology. 94(6). 933–941. 3 indexed citations

16.

Hassner, Avi, M. Lau, Edward J. Goetzl, & Daniel C. Adelman. (1993). Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide. Journal of Allergy and Clinical Immunology. 92(6). 891–901. 18 indexed citations

17.

Hassner, Avi & Daniel C. Adelman. (1991). Biologic Response Modifiers in Primary Immunodeficiency Disorders. Annals of Internal Medicine. 115(4). 294–307. 6 indexed citations

18.

Goetzl, E J, Paul Cheng, Avi Hassner, et al.. (1990). Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Clinical & Experimental Allergy. 20(s4). 3–7. 28 indexed citations

19.

Walters, Clifford A., et al.. (1988). Fixed cutaneous eruptions to seminal-plasma challenge: a case report. Fertility and Sterility. 50(3). 532–534. 13 indexed citations

20.

Sherr, Elliott H., et al.. (1988). Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency.. The Journal of Experimental Medicine. 168(1). 55–71. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact